1-11C-acetate kinetics of prostate cancer

Journal of Nuclear Medicine

Volumn 49, Issue 2, 2008, Pages 206-215

  Schiepers, Christiaan ^a   Hoh, Carl K ^b   Nuyts, Johan ^c   Seltzer, Marc ^a   Wu, Christine ^a   Huang, Sung Cheng ^a   Dahlbom, Magnus ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

1 11C acetate; Benign prostate hypertrophy; Factor analysis; Kinetic modeling; PET; Prostate cancer

Indexed keywords

1 ACETIC ACID C 11; ACETIC ACID C 11; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; CARBON; CARBON 11 ACETATE; CARBON-11 ACETATE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG UPTAKE; HUMAN; KINETICS; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECURRENT CANCER; BIOLOGICAL MODEL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; PROSTATE TUMOR; SCINTISCANNING;

ACETATES; AGED; CARBON; COMPUTER SIMULATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KINETICS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS;

EID: 38949156747     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.044453     Document Type: Article

References (39)

1. 11C-acetate PET in primary prostate cancer [abstract]. J Nucl Med. 2000;41(suppl 5):100P.
2. Schiepers C, Hoh CK, Nuyts J, Wu HM, Phelps ME, Dahlbom M. Factor analysis in prostate cancer: delineation of organ structures and automatic generation of in- and output functions. IEEE Trans Nucl Sci. 2002;49:2338-2343.
3. 11C-acetate whole-body PET. J Nucl Med. 2004;45:1233-1236.
4. 11C-acetate. J Nucl Med. 2003;44:556-558.
5. Kotzerke J, Volkmer BG, Neumaier B, Gschwend JE, Hautmann RE, Reske SN. Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer. Eur J Nucl Med Mol Imaging. 2002;29:1380-1384.
6. 11C-Acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181-186.
7. 11C-Acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med. 2003;44:549-555.
8. 11C] acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Eur J Nucl Med Mol Imaging. 2002;29:1492-1495.
9. Effert PJ, Bares R, Handt S, Wolff JM, Bull U, Jakse G. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorinelabeled deoxyglucose. J Urol. 1996;155:994-998.
10. Kotzerke J, Prang J, Neumaier B, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med. 2000;27:1415-1419.
11. Kotzerke J, Gschwend JE, Neumaier B. PET for prostate cancer imaging: still a quandary or the ultimate solution? J Nucl Med. 2002;43:200-202.
12. 11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin. 2003;42:25-30.
13. Lear JL. Relationship between myocardial clearance rates of carbon-11-acetate-derived radiolabel and oxidative metabolism: physiologic basis and clinical significance. J Nucl Med. 1991;32:1957-1960.
14. 11C]acetate as a tracer of cardiac oxidative metabolism. Am J Physiol. 1994;266:H1304-H1315.
15. Buck A, Wolpers HG, Hutchins GD, et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med. 1991;32:1950-1957.
16. van den Hoff J, Burchert W, Wolpers HG, Meyer GJ, Hundeshagen H. A kinetic model for cardiac PET with [1-carbon-11]-acetate. J Nucl Med. 1996;37:521-529.
17. 11C-acetate PET. J Nucl Med. 2001;42:1438-1439.
18. 11C-acetate. J Nucl Med. 2001;42:63-70.
19. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab. 1985;5:584-590.
20. Oberdorfer F, Theobald A, Prenant C. Simple production of [1-carbon-11]acetate. J Nucl Med. 1996;37:341-342.
21. Davenport RJ, Dowsett K, Pike VW. A simple technique for the automated production of no-carrier-added [1-carbon-11]acetate. Appl Radiat Isot. 1997;48:1117-1120.
22. Nuyts J, Dupont P, Mortelmans L. Iterative reconstruction of transmission sinograms with low signal to noise ratio. Paper presented at: 2nd IEEE Workshop on Computer Intensive Methods in Control and Signal Processing: Can We Beat the Curse of Dimensionality? August 28-30, 1996; Prague, Czech Republic.
23. Fessler J, Ficaro E, Clinthorne N, Lange K. Grouped-coordinate ascent algorithms for penalized likelihood transmission image reconstruction. IEEE Trans Med Imaging. 1997;16:166-175.
24. Hudson H, Larkin R. Accelerated image-reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601-609.
25. 11C]acetate. J Nucl Med. 1997;38:459-466.
26. Porenta G, Cherry S, Czernin J, et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med. 1999;26:1465-1474.
27. 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2003;30:607-611.
28. Costello LC, Franklin RB. Citrate metabolism of normal and malignant prostate epithelial cells. Urology. 1997;50:3-12.
29. Yoshimoto M, Waki A, Yonekura Y, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol. 2001;28:117-122.
30. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371-388.
31. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol. 1980;238:E69-E82.
32. 11C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med. 2001;42:1174-1182.
33. Draper NR, Smith H. Applied Regression Analysis. 2nd ed. New York, NY: John Wiley & Sons; 1981.
34. Landaw EM, DiStefano JJ 3rd. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol. 1984;246:R665-R677.
35. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716-723.
36. Wu HM, Hoh CK, Choi Y, et al. Factor analysis for extraction of blood timeactivity curves in dynamic FDG-PET studies. J Nucl Med. 1995;36:1714-1722.
37. Schiepers C, Hoh CK, Dahlbom M, Wu HM, Phelps ME. Factor analysis for delineation of organ structures, creation of in- and output functions, and standardization of multicenter kinetic modeling. Proc SPIE. 1999;3661:1343-1350.
38. Woodbury J. Regulation of pH. In: Ruch TaP HD, ed. Physiology and Biophysics. Philadelphia, PA: Saunders; 1965:899-934.
39. Schiepers C, Chen W, Dahlbom M, Cloughesy T, Hoh CK, Huang SC. 18FFluorothymidine kinetics of malignant brain tumors. Eur J Nucl Med Mol Imaging. 2007;34:1003-1011.